Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery.
André RiedlDenisa BojkováJiang TanÁbris JeneyPia-Katharina LarsenCsaba JeneyFlorian FullUlrich KalinkeZsolt RuzsicsPublished in: Vaccines (2024)
We investigated the basic characteristics of a new murine cytomegalovirus (MCMV) vector platform. Using BAC technology, we engineered replication-competent recombinant MCMVs with deletions of up to 26% of the wild-type genome. To this end, we targeted five gene blocks (m01-m17, m106-m109, m129-m141, m144-m158, and m159-m170). BACs featuring deletions from 18% to 26% of the wild-type genome exhibited delayed virus reconstitution, while smaller deletions (up to 16%) demonstrated reconstitution kinetics similar to those of the wild type. Utilizing an innovative methodology, we introduced large genomic DNA segments, up to 35 kbp, along with reporter genes into a newly designed vector with a potential cloning capacity of 46 kbp (Q4). Surprisingly, the insertion of diverse foreign DNAs alleviated the delayed plaque formation phenotype of Q4, and these large inserts remained stable through serial in vitro passages. With reporter-gene-expressing recombinant MCMVs, we successfully transduced not only mouse cell lines but also non-rodent mammalian cells, including those of human, monkey, bovine, and bat origin. Remarkably, even non-mammalian cell lines derived from chickens exhibited successful transduction.
Keyphrases
- wild type
- genome wide
- copy number
- genome wide identification
- cell free
- dna methylation
- epstein barr virus
- crispr cas
- endothelial cells
- circulating tumor
- genome wide analysis
- coronary artery disease
- high throughput
- induced pluripotent stem cells
- transcription factor
- cancer therapy
- gene expression
- atomic force microscopy
- mass spectrometry
- pluripotent stem cells
- climate change
- drug delivery
- diffuse large b cell lymphoma